Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    X-PECT
Show Display Options
Rank Status Study
1 Completed Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Capecitabine;   Drug: Perifosine;   Drug: Placebo

Indicates status has not been verified in more than two years